While obesity contributes to the development of SIBO by altering intestinal motility and promoting dysbiosis, it exacerbates MASLD through fat accumulation, insulin resistance, and other metabolic disruptions. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.